Integrating Bioprinting and Increased Throughput: Next-Generation Models for Cardiac Research

Area of Science:

• Biomedical Engineering
• Tissue Engineering
• Cardiovascular Research

Background:

• Three-dimensional cell culture (3DCC) and bioprinting (3DBP) technologies are crucial for developing engineered human cardiac tissue.
• 3DCC models offer superior replication of in vivo tissue characteristics compared to 2D systems.
• Advancements in 3DBP facilitate rapid, robust generation and real-time assessment of 3D tissues.

Purpose of the Study:

• To review trending cardiac tissue models and their integrated high-throughput screening (HTS) processes.
• To highlight the translational potential of engineered cardiac tissues in drug development.
• To emphasize the need for scale-up, compatibility, and standardization in HTS for cardiovascular applications.

Main Methods:

• Review of current literature on 3D cardiac tissue models and 3DBP techniques.
• Analysis of integrated high-throughput screening (HTS) methodologies.
• Discussion on the challenges and future directions for HTS in cardiovascular research.

Main Results:

• 3DCC and 3DBP models provide more accurate representations of cardiac tissue than traditional 2D cultures.
• HTS is essential for the clinical translation of bioprinted cardiac tissues for drug safety and efficacy testing.
• The integration of 3DBP models with HTS promises improved disease modeling and therapeutic evaluation.

Conclusions:

• The combination of 3DBP models and HTS is vital for advancing cardiovascular research and drug discovery.
• Standardization and scale-up of HTS processes are critical for realizing the full potential of engineered cardiac tissues.
• This synergistic approach can lead to more effective and safer cardiovascular therapeutics.